The deal size was increased to $502M in common stock from $400M in common stock. Jefferies, TD Cowen and Leerink acted as joint book running managers for the offering.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TERN:
- Terns Pharmaceuticals announces proposed offering of $400M of stock
- Terns Pharmaceuticals price target raised to $58 from $28 at Oppenheimer
- Terns Pharmaceuticals price target raised to $54 from $35 at BMO Capital
- Terns Pharmaceuticals price target raised to $56 from $35 at Truist
- Terns Pharmaceuticals price target raised to $54 from $33 at Mizuho